Skip to main content
Premium Trial:

Request an Annual Quote

When Faster IS Better

A WSJ op-ed piece by Richard Miller, an oncologist and the CEO of the Bay Area-based Pharmacyclics, argues that the FDA needs to get cancer drugs to market quicker. Maybe he should direct his eye toward Scottish scientists at the universities of Glasgow and Strathclyde, who are developing a large molecular sensing device they plan to use to test for signature patterns of drug side effects. The main reason for drugs failing to pass clinical trials are the potential side effects, this BBC article quotes one of the leading scientists as having said.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.